Article
Exhaled breath condensate efficacy to identify mutations in patients with lung cancer: A pilot study.
Nucleosides, nucleotides & nucleic acids - 1 Jan 2022
Kazeminasab Somayeh, Ghanbari Reza, Emamalizadeh Babak, Jouyban-Gharamaleki Vahid, Taghizadieh Ali, Jouyban Abolghasem, Khoubnasabjafari Maryam
Abstract excerpt
Exhaled breath condensate (EBC) is used to investigate the efficacy of EBC to detect the genetic mutations in patients with lung cancer. Samples of 5 patients and 5 healthy volunteers were collected. DNA was extracted and used for amplification of hotspot regions of TP53 and KRAS genes by using PCR. We performed the mutation analysis by direct sequencing in all subjects. Detected mutations in EBC samples were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
